Drugs / Lactobacillus plantarum strain 299
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03057054 | Apr 2018 → Jun 2022 overdue | acute graft versus host disease, leukemia, lymphoma | Children's Oncology Group | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus plantarum strain 299 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03057054 ↗ |
| Route | Oral | “Patients receive Lactobacillus plantarum strains 299 and 299v orally (PO) or through nasojejunal (NJ), nasogastric (NG) or gastronomy (G) tube once daily (QD) on day 1 of...” NCT03057054 ↗ |
| Route | Other | “Patients receive Lactobacillus plantarum strains 299 and 299v orally (PO) or through nasojejunal (NJ), nasogastric (NG) or gastronomy (G) tube once daily (QD) on day 1 of...” NCT03057054 ↗ |